小摩：维持中国人寿(02628)“增持”评级 目标价下调至15港元
摩根大通发布报告称，更新对中国人寿(02628)的分析模型，以反映第四季度的业务环境及市场财务状况。相对亚洲同业，中国人寿根据IFRS-17/9会计准则公布的财务资料并不足够，因此该行维持以现有财务数据作分析，将目标价由18港元下调至15港元，以反映第四季度债券回报下跌、股市疲弱、新业务价值前景复苏步伐较原先预期为慢，维持“增持”评级。
报告中称，公司年初至今股价跌幅已合理反映未来财务表现可能疲弱的因素。该行将今明两年新业务价值的预测下调，估计今年至2025年期间，新业务价值分别增长25%、11%及16%。
Reprinted from 引领外汇网，the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.